In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens (2021)

First Author: Lamerton R

Attributed to: Determining functional immunity after SARS-CoV-2 vaccination or natural infection in haemodialysis patients at high-risk of COVID-19 funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.11.22.21266681

Publication URI: http://dx.doi.org/10.1101/2021.11.22.21266681

Type: Preprint